10X Genomics Inc (TXG) earnings · rev $642.8M
These earnings events as JSON? API free 100/day10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
This TXG earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported TXG revenue for 2025-12-31 was $642.8M. Net income was -$43.5M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TXG currently screens at market cap $4.08B.
When the next TXG 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 5.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full TXG research stays on the stock page; the tape stays on the quote page.
TXG earnings FAQ
What are TXG's latest revenue and net income?
Latest cached 10X Genomics Inc (TXG) revenue for Dec 31, 2025 was $642.8M. Net income was -$43.5M. Statements: https://lician.com/financials/txg
What is TXG's latest diluted EPS?
Latest cached 10X Genomics Inc (TXG) diluted EPS for Dec 31, 2025 was -$0.35.
What period does the latest TXG earnings print cover?
The latest cached 10X Genomics Inc (TXG) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did TXG revenue change from the prior cached period?
Cached 10X Genomics Inc (TXG) revenue was up 5.2% from $610.8M (Dec 31, 2024) to $642.8M (Dec 31, 2025). Statements: https://lician.com/financials/txg
Where are TXG earnings listed?
Cached earnings facts for 10X Genomics Inc (TXG) are listed at https://lician.com/earnings/txg. Statements: https://lician.com/financials/txg
Not investment advice.